Data through FY2026 Q3 (Jun 30, 2026)
Pheast Therapeutics, Inc
Company profile for Pheast Therapeutics, Inc covers 5 filings across the reporting window. FY2026 certified median offer: $156,270.
- FY2026 certified median
- $156,270
- Total filings
- 5
- FY2026 25th–75th percentile
- $156,270–$156,270
- Top job title
- Manager, Formulation & Drug Product
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 2 | $157,000 | $157,000 | $157,000 |
| FY2025 | 1 | $134,000 | $134,000 | $134,000 |
| FY2026 (Q1–Q3) | 2 | $156,270 | $156,270 | $156,270 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Manager, Formulation & Drug Product2 filings
- Research Associate I2 filings
- Scientist I, Discovery1 filings
Top cities
- Redwood City3 filings
- Palo Alto2 filings